文献速递新发突发、热带与寄生虫病医院感染防控

BioFire® FilmArray® 脑膜炎/脑炎检测面板的诊断准确性:系统综述与荟萃分析

Diagnostic test accuracy of the BioFire® FilmArray® meningitis/encephalitis panel: a systematic review and meta-analysis.
PubMed 文献 · Clin Microbiol Infect · 2019-11-21

ME 面板汇总敏感度为 90%(95%CI 86-93%),特异度为 97%(95%CI 94-99%);假阳性判定从 11.4% 降至 4%(经裁定后),假阴性从 2.2% 降至 1.5%。结论认为诊断准确性高,但实施决策应个体化。

要点

  • ME 面板汇总敏感度 90%、特异度 97%,诊断准确性较高。
  • 肺炎链球菌是假阳性比例最高的病原,经裁定后假阳性降至 4%。
  • HSV-1/2、肠道病毒和新型隐球菌/格特隐球菌假阴性比例最高。

核心结论

  • 现有文献提示 ME 面板具有较高的诊断准确性。
  • 实施该检测的决策应基于患者群体需求、实验室能力和使用该检测的医护人员知识进行个体化。

研究设计与样本

  • 系统综述与诊断试验准确性荟萃分析,系统检索 PubMed 和 EMBASE 数据库至 2019 年 5 月。
  • 纳入提供 ME 面板与参考标准比较的敏感度和特异度数据的研究,并单独评估提供假阳性和假阴性细节及不一致结果裁定信息的研究。

主要发现

  • ME 面板汇总敏感度为 90%(95%CI 86-93%),汇总特异度为 97%(95%CI 94-99%)。
  • 在评估假阳性和假阴性进一步裁定的研究中,假阳性检出率在裁定前为 11.4%,裁定后为 4%。
  • 假阳性比例最高的病原为肺炎链球菌,其次为无乳链球菌。
  • 假阴性分离株在裁定前为 2.2%,裁定后为 1.5%;HSV-1 和 HSV-2、肠道病毒及新型隐球菌/格特隐球菌假阴性比例最高。
  • 假阴性新型隐球菌/格特隐球菌多见于抗原滴度阳性、正在治疗或疾病已清除的患者。

关键数值与推荐

  • ME 面板与社区获得性 ME 的参考标准方法进行比较。
  • 汇总敏感度 90%(95%CI 86-93%),汇总特异度 97%(95%CI 94-99%)。
  • 假阳性检出率裁定前 11.4%、裁定后 4%;假阴性分离株裁定前 2.2%、裁定后 1.5%。

临床怎么用

  • ME 面板可作为疑似社区获得性 ME 的快速诊断工具,但需结合临床背景解读结果。
  • 对肺炎链球菌阳性结果应警惕假阳性可能,必要时进行确认试验。
  • 对 HSV-1/2、肠道病毒和新型隐球菌/格特隐球菌阴性结果,在高度怀疑时不应完全排除感染。
  • 实施前应评估患者群体需求、实验室能力和医护人员对检测的认知。

局限性

  • 假阳性和假阴性分析仅基于部分评估裁定结果的研究,可能存在异质性。
  • 检索截止至 2019 年 5 月,未纳入此后发表的研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The FilmArray® meningitis/encephalitis (ME) panel is a multiplex PCR assay which can detect the most commonly identified pathogens in central nervous system infections. It significantly decreases the time to diagnosis of ME and data has yielded several positive outcomes. However, in part, reports of both false positive and false negative detections have resulted in concerns about adoption. OBJECTIVES: The aim was to evaluate the ME panel in a diagnostic test accuracy review. DATA SOURCES: The PubMed and EMBASE databases were systematically searched through May 2019. STUDY ELIGIBILITY CRITERIA: Eligible studies were those providing sensitivity and specificity data for the ME panel compared with a reference standard. Studies providing details on false positive and false negative results of the panel as well as further investigation (adjudication) of the discordant results between the panel and comparator assays were included and assessed separately. PARTICIPANTS: Patients with suspected ME for whom a panel was ordered were included. METHODS: The ME panel was compared to reference standard methods for diagnosing community-acquired ME. We performed a meta-analysis and calculated the summary sensitivity and specificity of the ME panel. Moreover, we evaluated the false positive and false negative results of the panel. RESULTS: Thirteen studies (3764 patients) were included in the review and 8 of them (3059 patients) were pooled in a meta-analysis. The summary estimates of sensitivity and specificity with 95% confidence intervals (CI) was 90% (95% CI 86-93%) and 97% (95% CI 94-99%), respectively. When we looked specifically at studies that assessed further the false positive and false negative results, false positive detections were 11.4% and 4% before and after adjudication, respectively. The highest proportion of false positive was observed for Streptococcus pneumoniae followed by Streptococcus agalactiae. False negative isolates were 2.2% and 1.5% before and after adjudication, respectively. Herpes simplex virus 1 and 2, enterovirus and Cryptococcus neoformans/gattii had the highest proportions of false negative determinations. False negative C. neoformans/gattii were mostly patients with positive antigen titres, on treatment or cleared disease. CONCLUSIONS: The currently available literature suggests that the ME panel has high diagnostic accuracy. However, the decision for implementation should be individualized based on the needs of the patient population, the capabilities of the laboratory, and the knowledge of the healthcare providers that will utilize the test.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Tansarli GS, Chapin KC. Diagnostic test accuracy of the BioFire® FilmArray® meningitis/encephalitis panel: a systematic review and meta-analysis. Clin Microbiol Infect. 2019. PMID: 31760115. doi:10.1016/j.cmi.2019.11.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。